Clinical Outcomes Following Capsulotomy Versus Capsular Bag Fixated Presbyopia Correcting Toric Intraocular Lenses
Published 2025 - 43rd Congress of the ESCRS
Reference: FP09.11 | Type: Free paper | DOI: 10.82333/rgg5-4594
Authors: David López Delgado* 1 , Valentin Tinguaro Díaz Alemán 1 , Andres Blasco Alberto 1 , Zaira Hernadez Gonzalez 2 , Luis Reyes Gallardo 1 , Gerardo Jose Reboso Prieto 1 , Paula Alonso Gonzalez 1 , Paula Martín Gutierrez 1
1Ophtalmology,CHUC,La Laguna,Spain, 2General practitioners,CHUC,La Laguna,Spain
Purpose
To compare the visual and functional outcomes of capsulotomy fixated (FEMTIS Mplus) versus capsular bag fixated (PanOptix) multifocal toric IOLs
Setting
It is a prospective, randomized, comparative, two-arm, single-center, single-surgeon study at Nethradhama Superspeciality Hospital, Jayanagar, Bengaluru
Methods
120 eyes were included in the study, 60 in each group. All patients underwent Femtosecond laser assisted cataract surgery (LENSAR). Group A included PanOptix toric IOL implanted in the capsular bag.Group B included Femtis M plus toric IOL clipped to the anterior capsulotomy. Toric IOL placement was guided by “IntelliAxis” (LENSAR).
On postoperative day 1, 7, and at 1,3 and 6 months,uncorrected and corrected distance and near vision (40 cm), intermediate acuity (60, 80 cm), mesopic contrast sensitivity (CSV 1000), Defocus curves, postoperative refractive cylinder, OSI using High-definition Analyzer, and rotational stability (iTrace, Tracey Technology, Texas) were assessed. QOV and patient satisfaction questionnaire was also obtained.
Results
Both the groups showed comparable uncorrected distance and near visual acuity at all postoperative visits. While PanOptix demonstrated better intermediate vision, FEMTIS Mplus showed significantly superior contrast sensitivity (p<0.05) and rotational stability (p<0.05). The study also found that a higher percentage of FEMTIS Mplus (100%) patients achieved postoperative astigmatism within ±0.25D, compared to the PanOptix group (91.7%) suggesting superior astigmatic correction. Overall dysphotopsia questionnaire and patient satisfaction scores were found to be better in the capsulotomy fixated IOL group.
Conclusions
Both the FEMTIS Mplus toric and PanOptix toric IOLs deliver excellent visual outcomes, each with its own strengths. The FEMTIS IOL excels in distance vision, rotational stability, and demonstrates lesser dysphotopsia, while the PanOptix IOL offers superior intermediate vision. Personalized patient selection remains key to optimizing visual outcomes and overall satisfaction. This study aims to support clinicians in educating patients about their IOL options, ensuring they can make well-informed decisions that align with their unique needs and lifestyle.